| Serial Number | 98579402 |
| Word Mark | THRIVE |
| Filing Date | Friday, May 31, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, March 27, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 15, 2025 |
| Goods and Services | Research and development in the field of genetically modified cells, namely research and development of manufacturing processes for the production of fit and proliferative T-cells exhibiting naive and stem cell memory phenotypes through gene editing and cell therapy manufacturing for the treatment of patients having solid tumors by eradicating metastatic cells |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 31, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, June 27, 2023 |
| First Use In Commerce Date | Tuesday, June 27, 2023 |
| Party Name | Affini-T Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
| Event Date | Event Description |
| Friday, May 31, 2024 | NEW APPLICATION ENTERED |
| Saturday, December 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 16, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, December 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 21, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 17, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, December 17, 2024 | NON-FINAL ACTION WRITTEN |